Tillkännagivande • Feb 21
Biome Technologies Announces Plans to De-List from AIM Biome Technologies plc shares fell more than 60% in London on February 21, 2025, after announcing plans to de-list from the AIM market, citing costs and an inability to raise fresh equity. Biome called a general meeting of shareholders for March 13 to approve the AIM de-listing, but it said shareholders representing 82.5% of all voting rights already have committed to vote in favour. Assuming the exit is approved, Biome said the cancellation will occur on March 21. Biome said becoming a private company will improve its "ability to execute its development and scale-up strategy". It explained: "The directors believe that raising significant equity through public markets is likely to be challenging in the short and medium term and potentially may not be at a valuation that is acceptable to shareholders." Biome shares are concentrated among a few individual shareholders, with no significant institutional ownership, it said, making the situation particularly difficult. Tillkännagivande • Oct 25
Biome Technologies plc Appoints Brian Samuel Geary as Non-Executive Director Biome Technologies plc announced that Mr. Brian Samuel Geary has been appointed as a Non-Executive Director of the Company with immediate effect. Mr. Geary has been an investor in Biome since 2016 and currently holds 27.72 per cent. of the Company's equity share capital. An electrical engineer by degree with a corporate career in senior roles in a variety of engineering and control companies, he now splits his time between running the Antrim Hills Spring Water Company and managing an investment portfolio with an emphasis on small quoted businesses. He is also a non-executive director of Creightons plc. Reported Earnings • Sep 26
First half 2024 earnings released: UK£0.21 loss per share (vs UK£0.28 loss in 1H 2023) First half 2024 results: UK£0.21 loss per share (improved from UK£0.28 loss in 1H 2023). Revenue: UK£2.34m (down 34% from 1H 2023). Net loss: UK£804.0k (loss narrowed 24% from 1H 2023). Revenue is forecast to grow 35% p.a. on average during the next 2 years, compared to a 5.5% decline forecast for the Chemicals industry in the United Kingdom. New Risk • Aug 27
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 6x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (UK£2.66m market cap, or US$3.53m). Tillkännagivande • Aug 22
Biome Technologies plc has completed a Follow-on Equity Offering in the amount of £0.16 million. Biome Technologies plc has completed a Follow-on Equity Offering in the amount of £0.16 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 3,200,000
Price\Range: £0.05
Transaction Features: Regulation S Board Change • Jul 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman John Standen was the last independent director to join the board, commencing their role in 2007. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Jul 10
Biome Technologies plc Announces Resignation of Simon Herrick as Non-Executive Director and Chair of the Audit and Remuneration Committees Biome Technologies plc announced that Simon Herrick, non-executive director and chair of the audit and remuneration committees, has resigned with immediate effect. Tillkännagivande • Jul 08
Biome Technologies plc Provides Earnings Guidance for the Year Ending December 31, 2024 Biome Technologies plc provided earnings guidance for the year ending December 31, 2024. For the year, the company expects revenues will be materially below current market expectations. Reported Earnings • Apr 30
Full year 2023 earnings released: UK£0.41 loss per share (vs UK£0.18 loss in FY 2022) Full year 2023 results: UK£0.41 loss per share (further deteriorated from UK£0.18 loss in FY 2022). Revenue: UK£6.98m (up 13% from FY 2022). Net loss: UK£1.56m (loss widened 132% from FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings. New Risk • Apr 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (UK£3.59m market cap, or US$4.47m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). New Risk • Feb 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (UK£4.82m market cap, or US$6.08m). Minor Risk Share price has been volatile over the past 3 months (9.8% average weekly change). Reported Earnings • Sep 29
First half 2023 earnings released: UK£0.28 loss per share (vs UK£0.17 loss in 1H 2022) First half 2023 results: UK£0.28 loss per share (further deteriorated from UK£0.17 loss in 1H 2022). Revenue: UK£3.57m (up 47% from 1H 2022). Net loss: UK£1.06m (loss widened 67% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Board Change • Jun 04
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Senior Independent Non-Executive Director Simon Herrick was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • May 26
Biome Technologies plc Appoints Martin Rushton-Turner as Non-Executive Director Biome Technologies plc announced that Martin Rushton-Turner has been appointed a Non-Executive Director of the company and will join the Board with immediate effect. Mr. Rushton-Turner is, and has been, a significant investor in Biome since 2010 and currently holds 13.31% of the voting rights in the Company and approximately 35% of the Company's Convertible Loan Notes. He retired from Swiss Reinsurance Group ("Swiss Re") in 2014 and has since focused his attention and resources on a number of early-stage companies and investments where his roles have included being an adviser, chairman or director. Mr. Rushton-Turner worked at Swiss Re from 2001 to 2014, initially as Head of the Strategic Transactions Group which focused on transactions between Swiss Re and corporate and financial institutions, from 2008 to 2010 as Head of Legacy, the division formed to house and manage down the "bad bank" businesses of Swiss Re, and thereafter as Special Advisor to the Swiss Re Group CFO. Prior to Swiss Re, Mr. Rushton-Turner was Head of the Debt Structuring Group at Greenwich NatWest, having joined NatWest in 1993. Mr. Rushton-Turner qualified as a chartered accountant at Coopers & Lybrand in 1990, as a Barrister in 1991 and as a New York attorney in 1992. He holds an LLB from University College London (UCL) and is an Honorary Fellow of UCL. Reported Earnings • Apr 27
Full year 2022 earnings released: UK£0.18 loss per share (vs UK£0.30 loss in FY 2021) Full year 2022 results: UK£0.18 loss per share (improved from UK£0.30 loss in FY 2021). Revenue: UK£6.19m (up 7.9% from FY 2021). Net loss: UK£671.0k (loss narrowed 41% from FY 2021). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Tillkännagivande • Nov 10
Biome Technologies plc Provides Earnings Guidance for the Year 2022 The Board of Biome Technologies plc believed that the change to forecasting methodology outlined above will, in the current economic circumstances, provide a more consistent basis by which the performance of Biome can be judged. This change to methodology has resulted in a marginal reduction in the Board's view of full year revenues for 2022 but no change to its view of loss before interest, depreciation, amortisation and share option charges or anticipated 2022 year-end cash. The Board's view of expected financial performance in 2023 is unchanged. Reported Earnings • Sep 23
First half 2022 earnings released: UK£0.17 loss per share (vs UK£0.19 loss in 1H 2021) First half 2022 results: UK£0.17 loss per share (improved from UK£0.19 loss in 1H 2021). Revenue: UK£2.43m (down 6.2% from 1H 2021). Net loss: UK£637.0k (loss narrowed 9.0% from 1H 2021). Revenue is forecast to grow 42% p.a. on average during the next 2 years, compared to a 8.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings. Price Target Changed • Apr 27
Price target increased to UK£5.00 Up from UK£4.37, the current price target is provided by 1 analyst. New target price is 144% above last closing price of UK£2.05. Stock is down 43% over the past year. The company is forecast to post a net loss per share of UK£0.17 next year compared to a net loss per share of UK£0.30 last year. Reported Earnings • Sep 17
First half 2021 earnings released: UK£0.19 loss per share (vs UK£0.29 loss in 1H 2020) The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: UK£2.59m (up 3.6% from 1H 2020). Net loss: UK£700.0k (loss narrowed 15% from 1H 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. Tillkännagivande • Jul 01
Biome Technologies plc Provides Revenues Guidance for the Years Ending 31 December 2021 and 2022 Biome Technologies plc provided revenues guidance for the years ending 31 December 2021 and 2022. For the period, the company now believes that Group revenues will be materially below current market expectations. Executive Departure • Apr 24
Senior Independent Non-Executive Director has left the company On the 21st of April, Michael Kayser's tenure in the role of Senior Independent Non-Executive Director ended. As of December 2020, Michael personally held only 4.07k shares (UK£10k worth at the time). A total of 4 executives have left over the last 12 months. Reported Earnings • Mar 26
Full year 2020 earnings released: UK£0.51 loss per share (vs UK£0.35 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: UK£5.71m (down 18% from FY 2019). Net loss: UK£1.54m (loss widened 76% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Tillkännagivande • Mar 26
Biome Technologies plc Provides Update on Earnings Guidance for the Year 2021 Biome Technologies plc provided update on earnings guidance for the year 2021. The company announced that trading in the first quarter of 2021 was in line with expectations and the outlook for the year remains unchanged. Tillkännagivande • Mar 17
Biome Technologies plc Secures £248,000 Via A Further Funding Contract Biome Technologies plc announced that it has secured £248,000 via a further funding contract to complete the development phase and reach commercial production of its biodegradable tree shelter project. This follows the Company's successful completion of an initial feasibility study to develop and test a new generation of biodegradable tree shelters to be made from the Company's novel bioplastics. This additional funding has come from the Government-backed Innovate UK agency as part of the Sustainable Innovation Fund (SBRI Phase 2) and will support a significant increase in project activity and facilitate further extensive laboratory testing of materials and UK-wide field trials with potential end-customers for the novel biodegradable tree shelters. In the UK, around 45 million trees are planted each year, most of those using non-biodegradable tree shelters for protection, with an estimated 2,500 tons of persistent plastics ending up annually in the natural environment after use. Plans to significantly increase tree planting as part of the UK's drive to mitigate climate change will exacerbate these problems. This project aims to curb such unnecessary levels of plastic pollution with a product that biodegrades in-situ after use. The project continues in close partnership with Suregreen, a leading manufacturer of tree shelters, whose team has broad experience in the manufacture and sales of such products. Suregreen will involve its forestry customers in product assessment of the biodegradable tree shelters. Tillkännagivande • Jan 13
Biome Technologies plc Announces the Successful Completion of its Three-Month Feasibility Project to Develop and Test a New Generation of Biodegradable Tree Shelters to Be Manufactured from the Company's Bioplastics Biome Technologies plc announced the successful completion of its three-month feasibility project to develop and test a new generation of biodegradable tree shelters to be manufactured from the Company's bioplastics. Tree shelters protect young trees and bushes from predation by animals. They are a well-proven and economic route to limiting losses in the first five years of a tree's life. Traditionally made from oil-based and non-biodegradable plastics, the majority of such shelters are never collected and eventually litter the environment with microplastics. In the UK, around 45 million trees are planted each year, most of those using non-biodegradable tree shelters for protection, with an estimated 2,500 tons of persistent plastics ending up annually in the natural environment after use. Plans to significantly increase tree planting as part of the UK's drive to mitigate climate change will exacerbate these problems.
The initial feasibility project has allowed the Company to explore the performance of a variety of bioplastic materials in this application and culminated in the manufacture of prototypes at Biome's customer's premises. Is New 90 Day High Low • Dec 30
New 90-day high: UK£2.35 The company is up 24% from its price of UK£1.90 on 01 October 2020. The British market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. Tillkännagivande • Nov 05
Biome Technologies plc Starts Biodegradable Tree Shelter Project Biome's Bioplastics division announces the start of a project to develop and test a new generation of biodegradable tree shelters made from the Company's bioplastics. The project has been awarded funding of £58,843 from the Government-backed Innovate UK agency. Tree shelters are used to protect young trees and bushes from predation by animals. They are a well-proven and economic route to limiting losses in the first 5-7 years of a tree's life. Traditionally made from oil-based and non-biodegradable plastics, it is believed that the majority of such shelters are never collected at the end of their life and litter the landscape with large and small plastic pieces. Plans to significantly increase tree planting as part of the UK's push to net zero emissions will exacerbate these problems. The objective of this feasibility project is to develop and manufacture prototypes of a novel bio-based, biodegradable tree shelter. These shelters will be designed to provide protection to growing trees, not hinder growth as trees reach maturity and biodegrade if not collected. The prototypes will initially be subjected to laboratory testing in accelerated ageing conditions. This three-month project is being undertaken in conjunction with Suregreen, a leading manufacturer of tree shelters. Suregreen's team has extensive experience in the manufacture and sales of tree shelters and will involve its forestry customers in product assessment. The project will draw on advice from Dr. Robert Elias of the Biocomposites team at the University of Bangor. Dr. Elias has experience in forest industries and particular expertise in bio-based polymers and natural anti-bacterial additives. The project is funded by Innovate UK's Sustainable Innovation Fund (SBRI Phase 1) that seeks, following COVID-19, to demonstrate the impact and potential of a clean growth led recovery and transition to net zero greenhouse gas emissions. Should this initial feasibility project prove successful, the Company may apply for further funding from SBRI Phase 2 in early 2021. It is envisaged that subsequent funding would be used to conduct extensive field trials. Tillkännagivande • Oct 29
Biome Technologies plc Announces the Appointment of Robert (Rob) Smith to the Board of the Company as Group Chief Financial Officer (CFO), Effective 30 November 2020 Biome Technologies plc announced the appointment of Robert (Rob) Smith to the Board of the Company as Group Chief Financial Officer (CFO), effective 30 November 2020. Most recently Rob served in the CFO and CEO roles at Filtronic plc, an AIM listed electronics designer and manufacturer of advanced filters, antennas and transceivers. Prior to this he was Finance Director of AIM listed APC Technology Group, a specialist distributor and manufacturer of electronic components and semiconductor products with a focus on green technology industries. Is New 90 Day High Low • Oct 26
New 90-day low: UK£1.55 The company is down 18% from its price of UK£1.90 on 28 July 2020. The British market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Oct 02
New 90-day low: UK£1.80 The company is down 10.0% from its price of UK£2.00 on 03 July 2020. The British market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. Reported Earnings • Sep 27
First half earnings released Over the last 12 months the company has reported total losses of UK£1.21m, with losses widening by 117% from the prior year. Total revenue was UK£6.06m over the last 12 months, down 19% from the prior year.